A later study by Hao et al. found that TGF-β acted as a tumor suppressor during the early stages of tumorigenesis, although at later stages it functioned as a tumor promoter by stimulating cancer cells to undergo EMT, and by activating tumor angiogenesis and cancer-associated fibroblasts20. The gene discussed is TGFB1; the disease is neoplasm.